Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 7 - You Need To See This

Mizuho Analyst Remains Bullish On The EV Sector; Finds Rivian Better Positioned

Mizuho analyst Vijay Rakesh reiterated his Buy ratings on Rivian Automotive, Inc (NASDAQ:RIVN) and the $65 price target. He saw RIVN as a pure play and a strong early mover in the EV market, focusing on the higher-growth SUV and light truck market and a robust commercial vehicle roadmap beginning with Amazon.Com, Inc. (NASDAQ:AMZN). Rivian is…

Benzinga

What Are Whales Doing With NIO

Someone with a lot of money to spend has taken a bearish stance on NIO (NYSE:NIO). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Michelle Wie West set to host new LPGA event at Liberty National in 2023 with unique junior element

The new Mizuho Americas Open will take June 1-4 in Jersey City, New Jersey.

USA Today Sports Media Group

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago quarter.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2022

Upgrades

Benzinga

5 Adobe Analysts React To Earnings Beat, Guidance Miss, Figma Acquisition

Adobe Inc (NASDAQ: ADBE) shares traded lower by another 4.5% on Friday after the stock dropped 17% on Thursday, its worst day since 2010.

Benzinga

Analysts Cheer Workday's Better Than Feared Q2 Amid Macro Concerns

Workday, Inc (NASDAQ:WDAY) clocked 21.9% revenue growth in Q2 to $1.54 billion, which beat average analyst estimates. The subscription revenues of $1.37 billion were up 22.8%. Workday reported EPS of $0.83, which beat average analyst estimates. Workday reported solid 2Q23 results highlighted with an uncertain macro backdrop pressuring sales much less than feared, Needham analyst…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Analysts Continue To See Upside In Salesforce Post Q2 Beat Despite Challenging Macros

Salesforce, Inc (NYSE:CRM) clocked 22% revenue growth to $7.72 billion in Q2, beating consensus. The EPS of $1.19 topped the consensus. The board approved a buyback of up to $10 billion. The Q3 and FY guidance were below the consensus. Mizuho analyst Gregg Moskowitz reiterated a Buy and cut the price target from $245 to $235.…

Benzinga

Salesforce Faces Price Target Cuts On Guidance Cut, Shares Slide

Salesforce Inc (NYSE: CRM) reported upbeat results for its second quarter, but lowered its annual projections.

Benzinga

IT Spending, Public Cloud, Observability, Cybersecurity Demand For 2023 Is Concerning According To This Analyst

Mizuho analyst Gregg Moskowitz recently hosted a conference call with a senior account executive at a large tech transformation vendor. The expert cited a generally softer demand environment in April and May due to macro challenges. He became bullish in recent months, characterized by solid demand in June and July.

Benzinga

Western Digital Price Target Cut By Analysts Post Q4 Beat

Western Digital Corp (NASDAQ:WDC) clocked 8% year-on-year revenue growth to $4.53 billion in Q4, beating the consensus of $4.49 billion. Non-GAAP EPS of $1.78 beat the consensus of $1.68. Barclays analyst Tom O'Malley had an Equal Weight and $55 price target. The market expected a reset, but the depths of decline and the exclusion…

Benzinga

6 Advanced Micro Devices Analysts React To Earnings Beat, Guidance Miss, Market Share Gains

Advanced Micro Devices, Inc. (NASDAQ: AMD) shares traded lower by 4.3% on Wednesday after the semiconductor giant reported better-than-expected second-quarter numbers but disappointed Wall Street with its third-quarter guidance.

Benzinga

Walmart To $142? Plus This Analyst Raises Price Target On McDonald's

Keybanc raised the price target for McDonald's Corporation (NYSE: MCD) from $285 to $290. However, Keybanc analyst Eric Gonzalez maintained the stock with an Overweight rating. McDonald's shares fell 0.3% to $256.23 in pre-market trading.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022

Upgrades

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga Before The Bell: Donald Trump's Presidential Bid, Facebook Testing Multiple Profiles, UnitedHealth Q2 Earnings Growth And Other Top Financial Stories Friday, July 15

CNBC Augmented Supply Best Way To Balance Rising Oil Prices, Says OECD Chief

Benzinga

What Are Whales Doing With NIO

A whale with a lot of money to spend has taken a noticeably bullish stance on NIO. Looking at options history for NIO (NYSE:NIO) we detected 17 strange trades.

Benzinga

Mizuho Maintains Neutral Rating for OGE Energy: Here's What You Need To Know

Mizuho has decided to maintain its Neutral rating of OGE Energy (NYSE:OGE) and raise its price target from $38.00 to $39.00. Shares of OGE Energy are trading down 4.62% over the last 24 hours, at $38.19 per share. A move to $39.00 would account for a 2.12% increase from the…

Benzinga

Benzinga Bulls And Bears Of The Week: AMC, Coinbase, Apple, Tesla And The Crypto Everyone Is Watching

Benzinga has examined the prospects for many investors' favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

NIO Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on NIO. Looking at options history for NIO (NYSE:NIO) we detected 19 strange trades.

Benzinga

Mizuho Slashes Price Targets Of Mastercard, Visa Out Of Precaution - Read Why

Mizuho analyst Dan Dolev maintained Mastercard Inc (NYSE:MA) with a Buy, cut the price target from $435 to $375, maintained Visa Inc (NYSE:V) with a Neutral, and lowered the Price Target from $235 to $215. The revival of the highly lucrative cross-border volumes following the COVID shock to the travel industry remains a significant component of the…

Benzinga

Find Out All About Mizuho's Top China Internet Sector Pick

Mizuho analyst James Lee recently hosted an investor call with Baidu, Inc (NASDAQ: BIDU) management. Firstly, Lee noted that the reopening has been orderly, and advertising is recovering faster than Cloud.

Benzinga

Thinking About Buying Stock Or Options In Robinhood Markets, Nio, Tesla Or Etsy?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends. Here are the latest analyst rating updates for Robinhood Markets, Nio, Tesla and Etsy:

Benzinga

Tesla, Rivian and NIO See Estimates and Price Targets Slash By Mizuho Post Battery Industry Call

Mizuho hosted a battery industry call looking at critical challenges, ramps, new technologies, and the longer-term outlook. It listed the key takeaways in a note titled "Battery Takeaways: Tesla the Leader, LFP Cost-Effective, Solid State Too Far Away."

Benzinga

Mizuho Maintains Buy Rating for Equity Residential: Here's What You Need To Know

Mizuho has decided to maintain its Buy rating of Equity Residential (NYSE:EQR) and lower its price target from $84.00 to $79.00. Shares of Equity Residential are trading up 2.32% over the last 24 hours, at $73.48 per share. A move to $79.00 would account for a 7.5% increase from the…

Benzinga

UniQure Shares Are Up After Low-Dose Cohort Data From Huntington's Gene Therapy Trial

UniQure N.V. (NASDAQ:QURE) announced safety and biomarker data from 10 patients enrolled in the low-dose cohort of the ongoing Phase 1/2 trial of AMT-130 gene therapy for Huntington's disease. Six of the ten enrolled patients received AMT-130, and four received an imitation surgical procedure in this randomized, blinded clinical trial in the U.S.…

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.